Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan in Reducing Weaning Failures of ECLS
NCT04158674Phase 3Terminated
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Feb 2020
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levosimendan in heart failure (HF), sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Started Feb 2020; status: terminated.
02
Drugs
levosimendan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT04158674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04158674.